Comment · Tue, December 5, 2017 · Ceretropic & Nootropics Depot
Neuralstem Presents Positive Updated Data from Phase 2 Study of NSI-189 in Major Depressive Disorder
What they were answering
Majalisk · 6 points
Ah, that’s why I just saw that they jumped 75%
u/MisterYouAreSoDumb · Ceretropic & Nootropics Depot
I almost thought I was looking at the wrong stock when I woke up and looked at my watch list. I never bought back in after selling at $6, though. I thought for sure they were heading toward delisting. Their executive team has no idea how to manage investor sentiment. I knew NSI-189 worked, but I did not think Neuralstem had what it took to get it to market. I still don't, to be honest.